CNS Events
The Promise -- and Potential Risks -- of Synthetic Biology
Synthetic biology is a new bioengineering discipline that aims to apply
the burgeoning knowledge of genomics and cellular physiology for
practical purposes. Among its goals is the design and assembly of
artificial microorganisms that can produce pharmaceuticals, detect toxic
chemicals, break down pollutants, repair defective genes, destroy cancer
cells, and generate hydrogen for the post-petroleum economy. As has been
the case with other powerful new technologies, however, synthetic biology
may create new risks for society, including unintended harmful
consequences for human health or the environment and deliberate misuse
for warfare or terrorism.
On December 6, 2006, the Center for Nonproliferation Studies hosted a
luncheon briefing on synthetic biology at its Washington, D.C., offices
featuring Dr. Raymond
Zilinskas, who directs the CBW Nonproliferation Program at the Monterey
Institute Center for Nonproliferation Studies. Amy E. Smithson, a Senior
Fellow at the Center for Strategic and International Studies, offered
feedback and commentary. The program was moderated by Michael Moodie.
The focus of the briefing was to assess the current status of research in
the field; examine the risks of this new technology for public health,
the environment, and national security; and suggest some policy options
for regulating it.
Return to the Press Room.
